Form 4: Apellis Pharmaceuticals VP James Chopas Sells Shares to Cover Tax Withholding
SEC Form 4
James George Chopas, VP/Chief Accounting Officer of Apellis Pharmaceuticals, sold 550 shares of common stock on September 3, 2024, to cover tax withholding obligations.
Summary
- On September 3, 2024, James George Chopas, VP/Chief Accounting Officer of Apellis Pharmaceuticals, sold 550 shares of the company's common stock.
- The sale was executed at a price of $39.491 per share.
- The transaction was conducted to cover tax withholding obligations related to the release of Restricted Stock Units on August 30, 2024.
- Following the transaction, Chopas directly owns 38,333 shares of Apellis Pharmaceuticals.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.
Industry Context
This is a routine Form 4 filing, reflecting an insider transaction related to tax obligations on equity compensation. It's common for executives to sell shares to cover these obligations.
Key Dates
| Date | Description |
|---|---|
| 08/30/2024 | Restricted Stock Units released |
| 09/03/2024 | Date of stock sale |
| 09/04/2024 | Date of signature on Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.